Nina Radosevic-Robin

Documents

Publications

	Microbial composition of tumour and its environment reflects the presence or absence of local lymph node metastases Rea Bingula , Edith Filaire , Jeremie Talvas , Émilie Thivat , Géraud Galvaing International Human Microbiome Consortium Congress, Jun 2021, Virtual conference, France. ⟨10.13140/RG.2.2.34861.41441⟩ Communication dans un congrès hal-03442853v1
	Sensitive and Specific Detection of Ewing Sarcoma Minimal Residual Disease in Ovarian and Testicular Tissues in an In Vitro Model Laure Chaput , Victoria Grèze , Pascale Halle , Nina Radosevic-Robin , Bruno Pereira BLEFCO CECOS, 2020, Paris, France Communication dans un congrès hal-03040417v1
	Hétérogénéité tumorale et échappement métastatique des carcinomes mammaires triples négatifs Noura Khaled , Nina Radosevic-Robin , Flora Ponelle-Chachuat , M. Roche , S. Viala Congrès Cancéropole Lyon Auvergne Rhône Alpes (CLARA), Apr 2019, Lyon, France Communication dans un congrès hal-02090761v1
	Sensitive and Specific Detection of Ewing Sarcoma Minimal Residual Disease in Ovarian and Testicular Tissues in an In Vitro Model Laure Chaput , Victoria Grèze , Pascale Halle , Nina Radosevic-Robin , Bruno Pereira BLEFCO CECOS, 2019, Paris, France Communication dans un congrès hal-03040426v1
	Homoharringtonine, a natural protein synthesis inhibitor, inhibits growth of triple negative breast cancer in vitro and in vivo Mohamad Yakhni , Arnaud Briat , Elisabeth Miot-Noirault , Florent Cachin , Frédérique Penault-Llorca Proceedings of the American Association for Cancer Research Annual Meeting 2018, Apr 2018, CHICAGO, United States Communication dans un congrès hal-01938956v1
	Assessment of a sensitive and specific method to detect ewing sarcoma minimal residual disease inn testicular and ovarian tissue by RT-qPCR (2018) Chaput L , Greze V , Halle P , A. Tchirkov , Veronese L 34th annual meeting of European society of Human Reproduction and Embryology, Jul 2018, Barcelone, Spain Communication dans un congrès hal-01935948v1
	Sensitive and Specific Detection of Ewing Sarcoma Minimal Residual Disease in Ovarian and Testicular Tissues in an In Vitro Model Laure Chaput , Victoria Grèze , Pascale Halle , Nina Radosevic-Robin , Bruno Pereira ESHRE, 2018, Barcelone, Spain Communication dans un congrès hal-03040432v1
	Détection de la maladie résiduelle du sarcome d’Ewing dans le tissu ovarien et testiculaire par une méthode sensible et spécifique Chaput L , Nina Radosevic-Robin , Kanold J , Andrei Tchirkov , Hanae Pons-Rejraji Collège de Biologie et médecine de la Reproduction, prix de la meilleure communication, Jul 2018, PARIS, France Communication dans un congrès hal-01936108v1
	Détection de la maladie résiduelle du sarcome d’Ewing dans le tissu ovarien et testiculaire par une méthode sensible et spécifique Laure Chaput , Nina Radosevic-Robin , Justyna Kanold , Tchirkov Andrei , Hanae Pons-Rejraji Collège de Biologie et médecine de la Reproduction, prix de la meilleure communication, Jul 2018, Paris, France Communication dans un congrès hal-03419088v1
	The ≥5% cut-off reveals tumor PD-L1 positivity as potential selection biomarker for patient enrollment into the trials evaluating anti-PD-1 or anti-PD-L1 agents in neoadjuvant treatment of triple negative breast cancer Wilfrid Finck , Judith Passildas , Camille Poirier , Fabrice Kwiatkowski , Catherine Abrial Breast Cancer Symposium, Dec 2018, SAN ANTONIO, United States Communication dans un congrès hal-01936152v1
	Sensitive and Specific Detection of Ewing Sarcoma Minimal Residual Disease in Ovarian and Testicular Tissues in an In Vitro Model Laure Chaput , Victoria Grèze , Pascale Halle , Nina Radosevic-Robin , Bruno Pereira Oncauvergnales, 2017, Clermont-Ferrand, France Communication dans un congrès hal-03040442v1
	Sensitive and Specific Detection of Ewing Sarcoma Minimal Residual Disease in Ovarian and Testicular Tissues in an In Vitro Model Laure Chaput , Victoria Grèze , Pascale Halle , Nina Radosevic-Robin , Bruno Pereira Collège de Médecine de la Reproduction, 2017, Paris, France Communication dans un congrès hal-03040438v1

	Pathologic Response to Neoadjuvant Sequential Chemoradiation Therapy in Locally Advanced Breast Cancer: Preliminary, Translational Results from the French Neo-APBI-01 Trial Nhu Hanh To , Isabelle Gabelle-Flandin , Thi My Hanh Luong , Gokoulakrichenane Loganadane , Nabila Ouidir Cancers, 2023, 15 (7), pp.2030. ⟨10.3390/cancers15072030⟩ Article dans une revue hal-04209898v1
	WISP2/CCN5 Suppresses Vasculogenic Mimicry through Inhibition of YAP/TAZ Signaling in Breast Cancer Cells Nathalie Ferrand , Aude Fert , Romain Morichon , Nina Radosevic-Robin , Maurice Zaoui Cancers, 2022, 14 (6), pp.1487. ⟨10.3390/cancers14061487⟩ Article dans une revue hal-03624131v1
	STING protects breast cancer cells from intrinsic and genotoxic-induced DNA instability via a non-canonical, cell-autonomous pathway Laura Cheradame , Ida Chiara Guerrera , Julie Gaston , Alain Schmitt , Vincent Jung Oncogene, 2021, 40 (49), pp.6627-6640. ⟨10.1038/s41388-021-02037-4⟩ Article dans une revue hal-03874137v1
	STING protects breast cancer cells from intrinsic and genotoxic-induced DNA instability via a non-canonical, cell-autonomous pathway Laura Cheradame , Ida Chiara Guerrera , Julie Gaston , Alain Schmitt , Vincent Jung Oncogene, 2021, 40, pp.6627-6640. ⟨10.1038/s41388-021-02037-4⟩ Article dans une revue hal-03438625v1
	RNA sequencing reveals the differential expression profiles of RNA in metastatic triple negative breast cancer and identifies SHISA3 as an efficient tumor suppressor gene Noura Khaled , Nicolas Sonnier , Ioana Molnar , Flora Ponelle-Chachuat , Myriam Kossai American Journal of Cancer Research, 2021, 11 (9) Article dans une revue hal-03426451v1
	Tumour-infiltrating lymphocytes in non-invasive breast cancer: A systematic review and meta-analysis Rafael Caparica , Marco Bruzzone , Elisa Agostinetto , Maria Alice Franzoi , Marcello Ceppi The Breast, 2021, 59, pp.183-192. ⟨10.1016/j.breast.2021.07.007⟩ Article dans une revue hal-03290357v1
	The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group Khalid El Bairi , Harry Haynes , Elizabeth Blackley , Susan Fineberg , Jeffrey Shear npj Breast Cancer, 2021, 7 (1), pp.150. ⟨10.1038/s41523-021-00346-1⟩ Article dans une revue hal-03467047v1
	INSTIGO Trial: Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse of Triple Negative Breast Cancer Hugo Veyssière , Sejdi Lusho , Ioana Molnar , Myriam Kossai , Maureen Bernadach Frontiers in Oncology, 2021, 11, pp.653370. ⟨10.3389/fonc.2021.653370⟩ Article dans une revue hal-03294072v1
	Recurrence biomarkers of triple negative breast cancer treated with neoadjuvant chemotherapy and anti-EGFR antibodies Nina Radosevic-Robin , Pier Selenica , Yingjie Zhu , Helen Won , Michael Berger npj Breast Cancer, 2021, 7 (1), ⟨10.1038/s41523-021-00334-5⟩ Article dans une revue hal-03349990v1
	Platelet-to-Lymphocyte Ratio Is Associated With Favorable Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Study on 120 Patients Sejdi Lusho , Xavier Durando , Marie-Ange Mouret-Reynier , Myriam Kossai , Nathalie Lacrampe Frontiers in Oncology, 2021, 11, ⟨10.3389/fonc.2021.678315⟩ Article dans une revue hal-03293733v1
	Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox Peter Dubsky , Katja Pinker , Fatima Cardoso , Giacomo Montagna , Mathilde Ritter Lancet Oncology, 2021, 22 (1), pp.e18-e28. ⟨10.1016/S1470-2045(20)30580-5⟩ Article dans une revue hal-03105550v1
	Anti-tumoral activity of the Pan-HER (Sym013) antibody mixture in gemcitabine-resistant pancreatic cancer models Emilia Rabia , Véronique Garambois , Julie Hubert , Marine Bruciamacchie , Nelly Pirot mAbs, 2021, 13 (1), pp.1914883. ⟨10.1080/19420862.2021.1914883⟩ Article dans une revue hal-03360283v1
	New insight into the role of ANXA1 in melanoma progression: involvement of stromal expression in dissemination. Solène Delorme , Maud Privat , Nicolas Sonnier , Jacques Rouanet , Tiffany Witkowski American Journal of Cancer Research, 2021, 11 (4), pp.1600-1615 Article dans une revue hal-03345236v1
	[18F]ML-10 PET imaging fails to assess early response to neoadjuvant chemotherapy in a preclinical model of triple negative breast cancer Elodie Jouberton , Sébastien Schmitt , Emmanuel Chautard , Aurélie Maisonial-Besset , Marie Roy EJNMMI Research, 2020, 10 (1), pp.2. ⟨10.1186/s13550-019-0587-5⟩ Article dans une revue hal-02489788v1
	PERCEPTION Trial protocol: Comparison of predictive and prognostic capacities of neutrophil, lymphocyte, and platelet counts and tumor-infiltrating lymphocytes in triple negative breast cancer Sejdi Lusho , Xavier Durando , Yannick Bidet , Ioana Molnar , Myriam Kossai Medicine (Baltimore), 2020, 99 (50), pp.e23418. ⟨10.1097/MD.0000000000023418⟩ Article dans une revue hal-03218998v1
	XENOBREAST Trial: A prospective study of xenografts establishment from surgical specimens of patients with triple negative or luminal b breast cancer Hugo Veyssière , Judith Passildas , Angeline Ginzac , Sejdi Lusho , Yannick Bidet F1000Research, 2020, 9, pp.1219. ⟨10.12688/f1000research.26873.1⟩ Article dans une revue hal-03038361v1
	Zeb1 expression by tumor or stromal cells is associated with spatial distribution patterns of CD8+ tumor-infiltrating lymphocytes: a hypothesis-generating study on 113 triple negative breast cancers. Mona Ouled Dhaou , Myriam Kossai , Anne-Pierre Morel , Mojgan Devouassoux-Shisheboran , Alain Puisieux American Journal of Cancer Research, 2020, 10 (10), pp.3370-3381 Article dans une revue hal-03046195v1
	An auristatin‐based antibody‐drug conjugate targeting HER3 enhances the radiation response in pancreatic cancer Laura Bourillon , Céline Bourgier , Nadège Gaborit , Véronique Garambois , Eva Lles International Journal of Cancer, 2019, 145 (7), pp.1838-1851. ⟨10.1002/ijc.32273⟩ Article dans une revue inserm-02074060v1
	Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance Simon Pernot , Magali Terme , Nina Radosevic-Robin , Florence Castan , Cecile Badoual Gastric Cancer, 2019, ⟨10.1007/s10120-019-00983-3⟩ Article dans une revue hal-02384138v1
	Homoharringtonine, an approved anti-leukemia drug, suppresses triple negative breast cancer growth through a rapid reduction of anti-apoptotic protein abundance Mohamad Yakhni , Arnaud Briat , Abderrahim El Guerrab , Ludivine Furtado , Fabrice Kwiatkowski American Journal of Cancer Research, 2019, 9 (5), pp.1043-1060 Article dans une revue hal-02343389v1
	Sensitive and Specific Detection of Ewing Sarcoma Minimal Residual Disease in Ovarian and Testicular Tissues in an In Vitro Model Laure Chaput , Victoria Grèze , Pascale Halle , Nina Radosevic-Robin , Bruno Pereira Cancers, 2019, 11, pp.1807. ⟨10.3390/cancers11111807⟩ Article dans une revue hal-02387351v1
	Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ Marie Beguinot , Marie-Mélanie Dauplat , Fabrice Kwiatkowski , Guillaume Lebouedec , Lucie Tixier BMC Cancer, 2018, 18 (1), ⟨10.1186/s12885-018-4013-6⟩ Article dans une revue hal-01912286v1
	Characterisation of gut, lung, and upper airways microbiota in patients with non-small cell lung carcinoma Study protocol for case-control observational trial Study Protocol Clinical Trial Rea Bingula , Marc Filaire , Nina Radosevic-Robin , Jean-Yves Berthon , Annick Bernalier Donadille Medicine, 2018, 97 (50), pp.e13676. ⟨10.1097/MD.0000000000013676⟩ Article dans une revue hal-02388057v1
	Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ Marie Beguinot , Marie-Mélanie Dauplat , Fabrice Kwiatkowski , Guillaume Lebouedec , Lucie Tixier BMC Cancer, 2018, ⟨10.1186/s12885-018-4013-6⟩ Article dans une revue hal-02387772v1
	Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno- Oncology Biomarker Working Group on Breast Cancer Maria Vittoria Dieci , Nina Radosevic-Robin , Susan Fineberg , Gert van den Eynden , Nils Ternes Seminars in Cancer Biology, 2018, 52, pp.16 - 25. ⟨10.1016/j.semcancer.2017.10.003⟩ Article dans une revue hal-02387991v1
	Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis Nina Radosevic-Robin , Wilhem Leconet , Myriam Chentouf , Stanislas Du Manoir , Clément Chevalier Clinical Cancer Research, 2017, 23 (11), pp.2806 - 2816. ⟨10.1158/1078-0432.CCR-16-1316⟩ Article dans une revue hal-01676378v1
	Desired turbulence? Gut-lung axis, immunity, and lung cancer Rea Bingula , Marc Filaire , Nina Radosevic-Robin , Mathieu Bey , Jean-Yves Berthon Journal of Oncology, 2017, 2017, pp.1-15. ⟨10.1155/2017/5035371⟩ Article dans une revue hal-01652921v1
	Combination of phosphotidylinositol-3-kinase targeting with cetuximab and irradiation: A preclinical study on an orthotopic xenograft model of head and neck cancer Alexandre Bozec , Nathalie Ebran , Nina Radosevic-Robin , Emmanuel Chamorey , Hedi Ben Yahia Archives of Otorhinolaryngology - Head & Neck Surgery, 2017, 39 (1), pp.151 - 159. ⟨10.1002/hed.24560⟩ Article dans une revue hal-01675150v1
	Ki67 assessment in breast cancer: an update Frédérique Penault-Llorca , Nina Radosevic-Robin Pathology, 2017, 49 (2), pp.166 - 171. ⟨10.1016/j.pathol.2016.11.006⟩ Article dans une revue hal-01675161v1
	Daily Practice Management of pT1a-b pN0 Breast Carcinoma: A Prospective French ODISSEE Cohort Study Florence Dalenc , Frédérique Penault-Llorca , Monique Cohen , Gilles Houvenaeghel , Jean-Marc Piat Clinical Breast Cancer, 2017, 17 (2), pp.107 - 116. ⟨10.1016/j.clbc.2016.08.007⟩ Article dans une revue hal-01675191v1
	Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer Maria Vittoria Dieci , Nina Radosevic-Robin , Susan Fineberg , Gert van den Eynden , Nils F Ternès Seminars in Cancer Biology, 2017, ⟨10.1016/j.semcancer.2017.10.003⟩ Article dans une revue hal-01675219v1
	A stemness-related ZEB1–MSRB3 axis governs cellular pliancy and breast cancer genome stability Anne Morel , Christophe Ginestier , Roxane Pommier , Olivier Cabaud , Emmanuelle Ruiz Nature Medicine, 2017, 23 (5), pp.568 - 578. ⟨10.1038/nm.4323⟩ Article dans une revue hal-01788395v1
	[Evaluation of the immune infiltrate in breast cancer]. Nina Radosevic-Robin , Marie Béguinot , Frédérique Penault-Llorca Bulletin du Cancer, 2017, 104 (1), pp.52 - 68. ⟨10.1016/j.bulcan.2016.11.010⟩ Article dans une revue hal-01675157v1
	DNA repair genes implicated in triple negative familial non-BRCA1/2 breast cancer predisposition Marie Ollier , Nina Radosevic-Robin , Fabrice Kwiatkowski , Flora Ponelle , Sandrine Viala American Journal of Cancer Research, 2015, 5 (7), pp.2113-2126 Article dans une revue hal-01647099v1
	Quantification of HER family receptors in breast cancer Paolo Nuciforo , Nina Radosevic-Robin , Tony Ng , Maurizio Scaltriti Breast Cancer Research, 2015, ⟨10.1186/s13058-015-0561-8⟩ Article dans une revue hal-02387771v1
	BRCA1 Induces Major Energetic Metabolism Reprogramming in Breast Cancer Cells Maud Privat , Nina Radosevic-Robin , Corinne Aubel , Anne Cayre , Frédérique Penault-Llorca PLoS ONE, 2014, 9, pp.102438 - 102438 Article dans une revue hal-01639617v1
	HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models Gaëlle Thomas , Thierry Chardès , Nadège Gaborit , Caroline Mollevi , Wilhem Leconet Oncotarget, 2014, 5 (16), pp.7138-7148. ⟨10.18632/oncotarget.2231⟩ Article dans une revue hal-02387994v2
	BRCA1 Induces Major Energetic Metabolism Reprogramming in Breast Cancer Cells Maud Privat , Nina Radosevic-Robin , Corinne Aubel , Anne Cayre , Frédérique Penault-Llorca PLoS ONE, 2014, 9 (7), ⟨10.1371/journal.pone.0102438⟩ Article dans une revue hal-02633594v1
	Morphological and immunohistochemical study of ovarian and tubal dysplasia associated with tamoxifen G. Chêne , Nina Radosevic-Robin , A. Tardieu , A. Cayre , I Raoelfils European Journal of Histochemistry, 2014, 58, ⟨10.4081/ejh.2014.2251⟩ Article dans une revue hal-02388062v1
	Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy. Wilhem Leconet , Christel Larbouret , Thierry Chardès , Gaëlle Thomas , Madeline Neiveyans Oncogene, 2014, 33 (47), pp.5405-14. ⟨10.1038/onc.2013.487⟩ Article dans une revue inserm-00916587v1

	Sensitive and Specific Detection of Ewing Sarcoma Minimal Residual Disease in Ovarian and Testicular Tissues in an In Vitro Model Laure Chaput , Victoria Grèze , Pascale Halle , Nina Radosevic-Robin , Bruno Pereira CNRC, 2017, Lille, France Poster de conférence hal-03040446v1
	Sensitive and Specific Detection of Ewing Sarcoma Minimal Residual Disease in Ovarian and Testicular Tissues in an In Vitro Model Laure Chaput , Victoria Grèze , Pascale Halle , Nina Radosevic-Robin , Bruno Pereira FFER, 2017, Tour, France Poster de conférence hal-03040444v1

Nina Radosevic-Robin

Publications

Microbial composition of tumour and its environment reflects the presence or absence of local lymph node metastases

Sensitive and Specific Detection of Ewing Sarcoma Minimal Residual Disease in Ovarian and Testicular Tissues in an In Vitro Model

Hétérogénéité tumorale et échappement métastatique des carcinomes mammaires triples négatifs

Sensitive and Specific Detection of Ewing Sarcoma Minimal Residual Disease in Ovarian and Testicular Tissues in an In Vitro Model

Homoharringtonine, a natural protein synthesis inhibitor, inhibits growth of triple negative breast cancer in vitro and in vivo

Assessment of a sensitive and specific method to detect ewing sarcoma minimal residual disease inn testicular and ovarian tissue by RT-qPCR (2018)

Sensitive and Specific Detection of Ewing Sarcoma Minimal Residual Disease in Ovarian and Testicular Tissues in an In Vitro Model

Détection de la maladie résiduelle du sarcome d’Ewing dans le tissu ovarien et testiculaire par une méthode sensible et spécifique

Détection de la maladie résiduelle du sarcome d’Ewing dans le tissu ovarien et testiculaire par une méthode sensible et spécifique

The ≥5% cut-off reveals tumor PD-L1 positivity as potential selection biomarker for patient enrollment into the trials evaluating anti-PD-1 or anti-PD-L1 agents in neoadjuvant treatment of triple negative breast cancer

Sensitive and Specific Detection of Ewing Sarcoma Minimal Residual Disease in Ovarian and Testicular Tissues in an In Vitro Model

Sensitive and Specific Detection of Ewing Sarcoma Minimal Residual Disease in Ovarian and Testicular Tissues in an In Vitro Model

Pathologic Response to Neoadjuvant Sequential Chemoradiation Therapy in Locally Advanced Breast Cancer: Preliminary, Translational Results from the French Neo-APBI-01 Trial

WISP2/CCN5 Suppresses Vasculogenic Mimicry through Inhibition of YAP/TAZ Signaling in Breast Cancer Cells

STING protects breast cancer cells from intrinsic and genotoxic-induced DNA instability via a non-canonical, cell-autonomous pathway

STING protects breast cancer cells from intrinsic and genotoxic-induced DNA instability via a non-canonical, cell-autonomous pathway

RNA sequencing reveals the differential expression profiles of RNA in metastatic triple negative breast cancer and identifies SHISA3 as an efficient tumor suppressor gene

Tumour-infiltrating lymphocytes in non-invasive breast cancer: A systematic review and meta-analysis

The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

INSTIGO Trial: Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse of Triple Negative Breast Cancer

Recurrence biomarkers of triple negative breast cancer treated with neoadjuvant chemotherapy and anti-EGFR antibodies

Platelet-to-Lymphocyte Ratio Is Associated With Favorable Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Study on 120 Patients

Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox

Anti-tumoral activity of the Pan-HER (Sym013) antibody mixture in gemcitabine-resistant pancreatic cancer models

New insight into the role of ANXA1 in melanoma progression: involvement of stromal expression in dissemination.

[18F]ML-10 PET imaging fails to assess early response to neoadjuvant chemotherapy in a preclinical model of triple negative breast cancer

PERCEPTION Trial protocol: Comparison of predictive and prognostic capacities of neutrophil, lymphocyte, and platelet counts and tumor-infiltrating lymphocytes in triple negative breast cancer

XENOBREAST Trial: A prospective study of xenografts establishment from surgical specimens of patients with triple negative or luminal b breast cancer

Zeb1 expression by tumor or stromal cells is associated with spatial distribution patterns of CD8+ tumor-infiltrating lymphocytes: a hypothesis-generating study on 113 triple negative breast cancers.

An auristatin‐based antibody‐drug conjugate targeting HER3 enhances the radiation response in pancreatic cancer

Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance

Homoharringtonine, an approved anti-leukemia drug, suppresses triple negative breast cancer growth through a rapid reduction of anti-apoptotic protein abundance

Sensitive and Specific Detection of Ewing Sarcoma Minimal Residual Disease in Ovarian and Testicular Tissues in an In Vitro Model

Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ

Characterisation of gut, lung, and upper airways microbiota in patients with non-small cell lung carcinoma Study protocol for case-control observational trial Study Protocol Clinical Trial

Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ

Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno- Oncology Biomarker Working Group on Breast Cancer

Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis

Desired turbulence? Gut-lung axis, immunity, and lung cancer

Combination of phosphotidylinositol-3-kinase targeting with cetuximab and irradiation: A preclinical study on an orthotopic xenograft model of head and neck cancer

Ki67 assessment in breast cancer: an update

Daily Practice Management of pT1a-b pN0 Breast Carcinoma: A Prospective French ODISSEE Cohort Study

Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer

A stemness-related ZEB1–MSRB3 axis governs cellular pliancy and breast cancer genome stability

[Evaluation of the immune infiltrate in breast cancer].

DNA repair genes implicated in triple negative familial non-BRCA1/2 breast cancer predisposition

Quantification of HER family receptors in breast cancer

BRCA1 Induces Major Energetic Metabolism Reprogramming in Breast Cancer Cells

HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models

BRCA1 Induces Major Energetic Metabolism Reprogramming in Breast Cancer Cells

Morphological and immunohistochemical study of ovarian and tubal dysplasia associated with tamoxifen

Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy.

Sensitive and Specific Detection of Ewing Sarcoma Minimal Residual Disease in Ovarian and Testicular Tissues in an In Vitro Model

Sensitive and Specific Detection of Ewing Sarcoma Minimal Residual Disease in Ovarian and Testicular Tissues in an In Vitro Model